Can a smartphone app help homeless vets with mental illness find their footing?

NCT ID NCT06138054

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study is testing a new approach called MI-CBTech that combines in-person counseling with a mobile phone app to help homeless veterans who have serious mental illnesses like schizophrenia. The goal is to help them set and achieve personal goals for community integration, such as finding work, socializing, or living independently. Fifty veterans will be randomly assigned to either MI-CBTech or a mindfulness program to see which is more feasible and acceptable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MI-CBTech (Motivational Interviewing and Cognitive Behavioral Therapy delivered via in-person sessions and a mobile phone app)
What this could lead to
If successful, this could point toward a practical, scalable way to help homeless veterans with serious mental illness reconnect with their communities and build meaningful daily routines.
What could go wrong
This is a very small pilot study (50 participants) focused on feasibility, not effectiveness. The intervention may not work as hoped, and results may not apply to other groups or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HOMELESSNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA

    RECRUITING

    West Los Angeles, California, 90073-1003, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.